Skip to main content
. 2018 May 9;8:7342. doi: 10.1038/s41598-018-25634-y

Table 2.

Metaanalysis of the association of the 24 SNPs with response to MTX assessed as ΔDAS28 at 6 months in the four populations of RA patients.

Locus SNP MA Fixed effects Heterogeneity Random effects
β (SE) P I2 P β (SE) P
Candidate gene
   ABCB1 rs1045642 A 0.02 (0.04) 0.6 28 0.2 0.02 (0.05) 0.7
   ABCC1 rs35592 C 0.03 (0.05) 0.6 71 0.02 −0.04 (0.10) 0.7
   AMPD1 rs17602729 A −0.11 (0.07) 0.10 61 0.05 −0.17 (0.12) 0.15
   ATIC rs4673990 G 0.08 (0.04) 0.07 6 0.4 0.08 (0.05) 0.09
rs12995526 A 0.04 (0.04) 0.4 36 0.2 0.02 (0.06) 0.7
rs16853834 T 0.04 (0.06) 0.6 11 0.3 0.04 (0.07) 0.6
rs2372536 G 0.07 (0.05) 0.1 17 0.3 0.07 (0.06) 0.2
   ITPA rs2295553 C 0.09 (0.04) 0.040 0 0.6 0.09 (0.04) 0.040
rs1127354 A 0.07 (0.09) 0.4 19 0.3 0.06 (0.10) 0.5
   MTRR rs1801394 A −0.14 (0.04) 0.0016 24 0.3 −0.15 (0.05) 0.0056
   MTHFD1 rs2236225 A −0.06 (0.05) 0.2 0 0.8 −0.06 (0.05) 0.2
   SLC46A1 rs2239907 T −0.01 (0.04) 0.7 0 0.6 −0.01 (0.04) 0.7
   TYMS rs699517 T −0.03 (0.05) 0.5 57 0.07 0.00 (0.08) 1.0
GWAS hit
   ARL14/PPM1L rs7624766 G −0.03 (0.05) 0.5 0 0.5 −0.03 (0.05) 0.5
   BMP2 rs2650972 T −0.04 (0.04) 0.4 0 0.8 −0.04 (0.04) 0.4
   DHFR rs5836788 del −0.01 (0.05) 0.8 0 0.5 −0.01 (0.05) 0.8
   10p15.1 rs1901633 G 0.05 (0.05) 0.3 0 0.7 0.05 (0.05) 0.3
   14q13.1 rs4982133 A −0.06 (0.05) 0.3 0 1.0 −0.06 (0.05) 0.3
   15q26.2 rs1703794 C −0.01 (0.05) 0.8 0 0.4 −0.01 (0.05) 0.8
   20q13 rs6064463 C −0.06 (0.05) 0.2 11 0.3 −0.06 (0.05) 0.3
   MTRR rs162040 C −0.07 (0.06) 0.3 60 0.06 −0.07 (0.11) 0.5
   PTPRM rs6506569 C 0.02 (0.05) 0.6 0 0.8 0.02 (0.05) 0.6
   TYMS rs2244500 G 0.02 (0.05) 0.6 64 0.04 0.07 (0.09) 0.4
rs2847153 A 0.02 (0.06) 0.7 0 0.5 0.02 (0.06) 0.7

Summary regression coefficients (β) and their standard errors (SE) obtained with fixed effects and random effects metaanalysis are presented together with the inconsistency (I2) and P value of the Cochran Q test for heterogeneity. Multivariate linear regression in each population included sex, age, baseline DAS28, previous use of DMARD and concomitant treatment with corticosteroids.